Catalyst
Slingshot members are tracking this event:
AstraZeneca (AZN) Presents CVD-REAL Data Evaluating SGLT-2 Inhibitors in Patients with Type 2 Diabetes at the American College of Cardiology 66th Annual Scientific Session
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AZN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 20, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cvd-real, Sglt-2 Inhibitors, Type 2 Diabetes, Hospitalization, Heart Failure, American College Of Cardiology, 66th Annual Scientific Session
